Biomarker validation is the process of determining the accuracy and reliability of a biomarker for use in medical research and diagnostics. It involves the evaluation of the biomarker's ability to accurately measure a biological process or disease state, as well as its ability to predict the outcome of a medical intervention. The validation process typically includes laboratory testing, clinical trials, and statistical analysis. The biomarker validation market is a rapidly growing sector of the biotechnology industry, driven by the increasing demand for personalized medicine and the need for more accurate and reliable biomarkers. Companies in this market are focused on developing and validating biomarkers for a variety of diseases and conditions, including cancer, cardiovascular disease, and neurological disorders. Some of the major companies in the biomarker validation market include Illumina, Qiagen, Thermo Fisher Scientific, Roche, and Agilent Technologies. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
